Flemming Ornskov

Flemming Ornskov, MD, MPH, is the Chief Executive Officer of Galderma, a global dermatology company dedicated to advancing dermatological solutions across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. With a background in medicine and public health, Ornskov leads Galderma’s transformation into a dermatology powerhouse, focusing on innovation, scientific leadership, and global growth. His online presence primarily highlights Galderma’s achievements, including product launches, clinical trials, and partnerships with healthcare professionals. Ornskov frequently shares insights on dermatological advancements, emphasizing evidence-based solutions and the company’s commitment to addressing diverse skin health needs.